Related Experiment Video

Updated: Jul 9, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

Five clinical conundrums in the management of giant cell arteritis

Maria C Cid1, Ana García-Martínez, Ester Lozano

  • 1Vasculitis Research Unit, Department of Internal Medicine, Hospital Clínic, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain. mccid@clinic.ub.es

Rheumatic Diseases Clinics of North America
|November 27, 2007
PubMed

Insights

Giant cell arteritis (GCA) management presents challenges, with persistent visual loss and complications like aneurysms. Current therapies offer limited steroid-sparing options, highlighting unmet needs in treating this large vessel vasculitis.

Area of Science:

  • Rheumatology
  • Internal Medicine
  • Vascular Medicine

Background:

  • Giant cell arteritis (GCA) is a leading cause of secondary vasculitis in adults over 50.
  • Despite available treatments, significant challenges persist in managing GCA, including visual loss and vascular complications.
  • Glucocorticoid therapy, while effective, is associated with substantial iatrogenic morbidity.

Purpose of the Study:

  • To review and address five major clinical conundrums in the management of giant cell arteritis.
  • To highlight unresolved issues and guide future therapeutic strategies for GCA patients.
  • To provide an overview of current challenges in GCA treatment and patient outcomes.

Main Methods:

  • Literature review of recent clinical trials and guidelines.
  • Analysis of unresolved clinical challenges in GCA management.
  • Synthesis of current evidence on GCA complications and treatment efficacy.

Main Results:

  • Visual loss remains a significant complication in 15-20% of GCA patients despite therapy.
  • Aneurysm formation and large vessel stenosis are increasingly recognized complications.
  • No efficient steroid-sparing agent has been identified in recent trials, leading to glucocorticoid-related morbidity.

Conclusions:

  • Effective management of GCA requires addressing persistent visual loss and vascular complications.
  • Development of novel, steroid-sparing therapies is crucial to reduce treatment-related morbidity.
  • Further research is needed to resolve key clinical conundrums in GCA management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...